Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir

A patient with genotype 1b chronic hepatitis C virus who had been treated with pegylated interferon and ribavirin (RBV) was treated with glecaprevir/pibrentasvir (GLE/PIB) for 12 weeks. A sustained virological response at post-treatment week 12 (SVR12) was achieved, but relapse occurred approximatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Manabe, Takushi, Tadokoro, Tomoko, Nakahara, Mai, Ohura, Kyoko, Fujita, Koji, Tani, Joji, Morishita, Asahiro, Ogawa, Chikara, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518557/
https://www.ncbi.nlm.nih.gov/pubmed/36450472
http://dx.doi.org/10.2169/internalmedicine.0865-22

Ejemplares similares

Ejemplares similares